Eleven Therapeutics

🌟 Exciting Opportunity Alert! 🌟 Are you a passionate Nucleic Acid Chemist looking to make a real impact in the world of RNA therapeutics? Eleven Therapeutics is on the hunt for a talented Oligonucleotide Chemist to join our dynamic team in Cambridge, UK! 🧬💼 If you're ready to be part of a creative and innovative group that's transforming drug discovery with cutting-edge RNA biology, combinatorial chemistry, and A.I., this is the perfect role for you! 🤩✨ 🔍 What We're Looking For: - Expertise in solid phase synthesis (SPS) and automated ON synthesizers - Strong background in oligonucleotide chemistry - Collaborative spirit and a drive for excellence Join us in our mission to develop next-gen nucleic acid therapeutics and make a difference in patients' lives across the globe! 🌍❤️ Interested? Apply now or share with someone who would be a great fit! https://lnkd.in/d8e6HEfc #JobOpening #ChemistryJobs #RNAtherapeutics #JoinOurTeam #ElevenTx #CambridgeJobs

🦀 🦑 🐳 Excited to be at Biomed Israel 2024, the leading life sciences and health tech event! This week, 150 startups and industry leaders are gathering in Tel Aviv to explore innovations shaping healthcare. Join us Wednesday for a special session moderated by Dr. Iris Grossman, PhD and Dr. Boaz Hirshberg. They will focus on revolutions in cardio-metabolism. Iris, our CTxO responsible for pharmaceutical and business development at Eleven Therapeutics, says: “The existing drugs are excellent, but the industry strives to upgrade them in several ways: lowering the dose and frequency of injections, minimizing side effects, increasing weight loss, and targeting fat rather than muscle. This will make these treatments more effective long-term and improve patient compliance.” Discover how Israeli experts and startups are enhancing treatments for better patient outcomes. Read more: https://lnkd.in/dXMNmJAm #BiomedIsrael #HealthcareInnovation #CardioMetabolismRevolution 🚀🔬

🌟Thrilled to welcome Miri Shiradski to our Chemistry team as an Analytical Chemist 🌟 👩🔬 With valuable experience from the industry and a Master's degree from the University of Warwick, Miri brings with her a wealth of experience and expertise that will undoubtedly elevate our capabilities here at Eleven Therapeutics. Her proficiency in HPLCs, LCMSs, and other analytical techniques, coupled with her proactive approach to method development, will enhance our purification and QC efforts 💪 Welcome aboard, Miri! 🎉 #11TX #Biotech #Science #Welcome

🎺🎺🎺 Check out the newest addition of our “home-made” molecule design and tracking tool! ⭐️⭐️⭐️ We created a ‘Walmart of building blocks’ for programmable molecules, so our scientists can go in, shop around 🛒 and easily design. It’s simple and insightful. 💡💡💡 #11TX #datasolutions #rnatherapeutics #Notion

🎙️ New Podcast Alert! Our very own CEO, Dr. Yaniv Erlich was recently featured on “Geekonomy”, one of the prominent podcasts in Israel, offering insights on groundbreaking advancements in genetic medicine, the fascinating world of slimming drugs and much more. Whether you're passionate about science, health, or simply curious about the latest innovations (and a Hebrew speaker), this podcast is for you. Tune in to stay ahead of the curve in the ever-evolving landscape of biotech and healthcare: https://lnkd.in/dD8rJ_nw #Biotechnology #Healthcare #Innovation #Podcast #11TX

💥 When Paloma Giangrande, our CTO, was asked by STAT what is her favorite lab equipment, she gave a brilliant answer! 📱 Read her interview now :) https://shorturl.at/ehmsG #biotech #11TX

👑 We’re thrilled to extend a warm welcome to André Filipe Dias Xavier, our newest addition to the Discovery Team in Cambridge, UK. Andre brings a wealth of experience, having spent six years in academic and industry settings after his Master's thesis at Aalborg University. His expertise includes molecular biology and clinical samples, which will support our drug development efforts.  We are confident that Andre’s diverse skill set and industry background will be invaluable to our team. Join us in welcoming André as we embark on new scientific endeavors at Eleven Therapeutics! 😎 🤖 #biotech #11TX

🚀 Exciting Announcement at JPM Healthcare Conference! 🌐 We are thrilled to share that at the JPM Healthcare Conference on January 9th, Dong-A ST and Eleven Therapeutics inked a Memorandum of Understanding (MoU). Under this MOU, the companies will focus on developing RNA-based therapies for fibrotic diseases using Eleven’s high throughput screening platform, TERÅ®, which is used to find the most suitable non-canonical elements in therapeutic xRNA molecules. We are excited to put together this collaboration with Dong-A ST and expand our R&D efforts to tackle unmet medical needs in fibrotic disorders. Dong-A ST’s team brings a wealth of experience in this therapeutic area, complementing Eleven’s prowess in next generation mRNAs. This partnership can allow us to expand into new markets, and adds to our growing set of collaborations, ultimately aimed to accelerate the translation of our groundbreaking xRNA modality into a solution for a multitude of devastating ailments. Read more: https://shorturl.at/cpERV #11TX #HealthcareInnovation #GeneTherapy #Biotechnology #Partnership #MedicalResearch #JPMHealthcareConference #FibrosisTreatment 💊